Universkin is a physician dispensed bespoke skincare, bridging skincare and functional dermatology. The brand’s personalized skincare are successfully used by dermatologists, plastic surgeons and aesthetic practitioners in 23 countries worldwide.
With the aim of further expanding its business activities in the area of dermatological treatments, Austria´s Croma-Pharma GmbH signed a comprehensive exclusive licensing and distribution agreement with Universkin SAS of France for European countries, namely Germany, Austria, France, Poland, Spain, Portugal, the Netherlands and overseas territories such as Australia, Canada and Brazil.
The agreement entered into force on the 1st of January 2017 and was concluded for at least 8 years.
"Thanks to this promising collaboration with Croma-Pharma, we are enhancing our sales structure in important markets and significantly improve Universkin’s commercial activity through the recognized expertise of the innovation-driven family-owned company Croma-Pharma," says Dr. Charalampos Arampatzis, CEO and co-owner of Universkin SAS.
Under its premium brand Princess®, which is exclusively available through dermatologists and pharmacies, Croma-Pharma already offers a comprehensive range of products in the field of non-invasive and minimally-invasive aesthetic medicine. The portfolio includes products based on Hyaluronic Acid like intradermal fillers, lifting threads, face masks, serums and the True Hyaluron series.
"With Universkin, we are able to implement the most innovative concept in the field of personalized skincare and a unique medical education system into our portfolio. Doing so, Croma-Pharma underlines its leading position as an innovator in the field of non-invasive and minimally invasive aesthetic medicine," concludes Mag. Pharm. Andreas Prinz, CEO and co-owner of Croma-Pharma GmbH.